Fission of 1000 kg U-233 produces several chemicals essential for industry, readily extracted from a LFTR, including 150kg xenon, 125kg neodymium (high-strength magnets), 20kg medical molybdenum-99, 20kg radiostrontium, zirconium, rhodium, ruthenium, and palladium.
LFTRs also produce non-fissile Pu-238, that conventional reactors can’t produce isolated from highly fissile Plutonium-239; Pu-238 is needed for radioisotope power such as for NASA deep space exploration vehicles (none left, only Th to U-233 makes Pu-238 w/o Pu-239).
(Extracting these from fuel rods in a solid fuel reactor would be extremely difficult.)
Radioactive isotopes are needed for medical treatment, including highly-targeted cancer treatments. These are currently very rare, since they have half-lives of a few days. LFTRs would produce these as part of the decay of U-233, and they would be easy to remove from the fuel salt.
Iodine-131 is used to treat cancers of the thyroid.
Thorium-229 for cancer treatments, decays to Bismuth-213, which decays through alpha emission (unlike most of the fission products that decay through beta emission). By binding Bi-213 to an antibody, it can be directed swiftly to a cancerous cell. The alpha decay of the Bi-213 then has a high probability of killing the cancer cell. (Very small amount/treatment, but decays fast to Bi-209.)